Homocysteine and cardiovascular disease
Authors:
Open Access
- 1 August 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 89 (8) , 561-563
Abstract
John Scott, Donald Weir; Homocysteine and cardiovascular disease, QJM: An International Journal of Medicine, Volume 89, Issue 8, 1 August 1996, Pages 561–563,Keywords
This publication has 18 references indexed in Scilit:
- The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemiaQJM: An International Journal of Medicine, 1996
- Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarctionQJM: An International Journal of Medicine, 1996
- A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defectsQJM: An International Journal of Medicine, 1995
- Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British menThe Lancet, 1995
- World distribution of factor V LeidenThe Lancet, 1995
- Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery StenosisNew England Journal of Medicine, 1995
- Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly PopulationJAMA, 1993
- Metabolic evidence that deficiencies of vitamin B−12 (cobalamin), folate, and vitamin B−6 occur commonly in elderly peopleThe American Journal of Clinical Nutrition, 1993
- Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.Circulation, 1993
- Homocysteine theory of arteriosclerosisAtherosclerosis, 1975